Sign in

CIK 0001570562

  • Accelerated filer

Evolus, Inc.

Sign in to watch
Ticker
EOLS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
461385614
Phone
+1 949-284-4555
Business address
520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
Former names
Evolus, Inc.
  1. 4 Open-market sale 10% owner sold 38,304 shares at $8.99 ($344,418)
  2. 4 Open-market sale 10% owner sold 6,848 shares at $8.95 ($61,290)
  3. 4 Open-market sale 10% owner sold 97,000 shares at an average $10.29 ($997,778)
  4. 4 Open-market buy Director bought 10,000 shares at an average $10.39 ($103,938)
  5. 4/A Open-market buy Director bought 5,000 shares at $10.05 ($50,250)
  6. 4 Open-market sale 10% owner sold 36,000 shares at an average $10.47 ($376,890)
  7. 4 Open-market buy Director bought 4,967 shares at $10.05 ($49,918)
  8. 4 Open-market buy Director bought 20,000 shares at $9.24 ($184,844)
  9. 4 Open-market buy Director bought 10,000 shares at $9.10 ($91,048)
  10. 4 Grant or award Chief Financial Officer acquired 36,443 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Open-market sale 10% owner sold 26,000 shares at $13.28 ($345,361)
  13. 4 Open-market sale MOATAZEDI DAVID sold 55,321 shares at $13.64 ($754,307)
  14. 4 Open-market sale SILVERNAIL LAUREN P sold 68,204 shares at an average $12.78 ($871,380)
  15. 4 Open-market sale Director sold 10,313 shares at an average $13.35 ($137,664)
  16. 4 Open-market sale MOATAZEDI DAVID sold 6,104 shares at $11.62 ($70,928)
  17. 4 Open-market sale Chief Marketing Officer sold 6,495 shares at $9.73 ($63,166)
  18. 4 Open-market sale MOATAZEDI DAVID sold 37,972 shares at $9.73 ($369,293)
  19. 4 Open-market sale Avelar Rui sold 10,192 shares at $9.73 ($99,121)
  20. 4 Open-market sale SILVERNAIL LAUREN P sold 10,192 shares at $9.73 ($99,121)

Page 6 of 13 · 252 filings